Prognostic Significance of "short-term" Effects of Chemotherapy on MYC and Histone H3 MRNA Levels in Acute Leukemia Patients

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1988 May 1

PMID 3285345

Citations 4

Authors

D Venturelli

B Lange

F Narni

L Selleri

M T Mariano

U Torelli

A M Gewirtz

B Calabretta

Affiliations

Soon will be listed here.

Abstract

We have found that administration of chemotherapy alters expression of growth-regulated genes in leukemia blast cells. To determine if such changes might be correlated with therapeutic outcome, we studied steady-state mRNA levels of MYC and histone H3 in the leukemic blasts of patients just prior to and 24 hr after the administration of the first doses of antileukemic drug therapy. Among nine patients with acute myelogenous leukemia, mRNA levels of MYC and histone H3 were reduced in five patients, and hematologic remission was achieved in three of these individuals. No remission was obtained in the four patients without reduction in MYC and histone H3 mRNA. Among acute lymphocytic leukemia patients, the mRNA levels of MYC and/or histone H3 were reduced by the therapy in seven of nine patients. A complete hematologic remission was obtained in five of them, and a partial remission was obtained in the other two. No remission was obtained in the patients in which MYC and H3 mRNA levels were unaffected by the therapy. These studies are of interest because they suggest that a decrease in the mRNA levels of MYC and histone H3 24 hr after a single dose of antineoplastic drugs may predict which patients will achieve complete remission; lack of reduction in these mRNAs correlates with failure to achieve remission. In addition, these studies also provide further proof of the heterogeneity of altered growth regulation among human leukemias.

Citing Articles

MiR-449a-5p mediates mitochondrial dysfunction and phenotypic transition by targeting Myc in pulmonary arterial smooth muscle cells.

Zhang C, Ma C, Zhang L, Zhang L, Zhang F, Ma M J Mol Med (Berl). 2019; 97(3):409-422.

PMID: 30715622 DOI: 10.1007/s00109-019-01751-7.

Histone H4 expression is cooperatively maintained by IKKβ and Akt1 which attenuates cisplatin-induced apoptosis through the DNA-PK/RIP1/IAPs signaling cascade.

Wang R, Zheng X, Zhang L, Zhou B, Hu H, Li Z Sci Rep. 2017; 7:41715.

PMID: 28139737 PMC: 5282510. DOI: 10.1038/srep41715.

Molecular characterization of the in vivo alkylating agent resistant murine EMT-6 mammary carcinoma tumors.

Chatterjee D, Liu C, Northey D, Teicher B Cancer Chemother Pharmacol. 1995; 35(5):423-31.

PMID: 7850925 DOI: 10.1007/s002800050257.

Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.

Gekeler V, FRESE G, Noller A, Handgretinger R, Wilisch A, Schmidt H Br J Cancer. 1992; 66(3):507-17.

PMID: 1355660 PMC: 1977945. DOI: 10.1038/bjc.1992.304.

References

Oudet P, Chambon P . Isolation of high-molecular-weight DNA from mammalian cells. Eur J Biochem. 1973; 36(1):32-8. DOI: 10.1111/j.1432-1033.1973.tb02881.x. View

Torelli U, Selleri L, Venturelli D, Donelli A, Emilia G, Ceccherelli G . Differential patterns of expression of cell cycle-related genes in blast cells of acute myeloid leukemia. Leuk Res. 1986; 10(10):1249-54. DOI: 10.1016/0145-2126(86)90244-4. View

Bennett J, Catovsky D, Daniel M, Flandrin G, GALTON D, Gralnick H . Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976; 33(4):451-8. DOI: 10.1111/j.1365-2141.1976.tb03563.x. View

Rigby P, Dieckmann M, Rhodes C, Berg P . Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol. 1977; 113(1):237-51. DOI: 10.1016/0022-2836(77)90052-3. View

Wahl G, Stern M, Stark G . Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate. Proc Natl Acad Sci U S A. 1979; 76(8):3683-7. PMC: 383897. DOI: 10.1073/pnas.76.8.3683. View

Thomas P . Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci U S A. 1980; 77(9):5201-5. PMC: 350025. DOI: 10.1073/pnas.77.9.5201. View

Suggs S, Wallace R, Hirose T, Kawashima E, Itakura K . Use of synthetic oligonucleotides as hybridization probes: isolation of cloned cDNA sequences for human beta 2-microglobulin. Proc Natl Acad Sci U S A. 1981; 78(11):6613-7. PMC: 349099. DOI: 10.1073/pnas.78.11.6613. View

Dalla-Favera R, Gelmann E, Martinotti S, Franchini G, Papas T, Gallo R . Cloning and characterization of different human sequences related to the onc gene (v-myc) of avian myelocytomatosis virus (MC29). Proc Natl Acad Sci U S A. 1982; 79(21):6497-501. PMC: 347154. DOI: 10.1073/pnas.79.21.6497. View

Heintz N, Sive H, Roeder R . Regulation of human histone gene expression: kinetics of accumulation and changes in the rate of synthesis and in the half-lives of individual histone mRNAs during the HeLa cell cycle. Mol Cell Biol. 1983; 3(4):539-50. PMC: 368569. DOI: 10.1128/mcb.3.4.539-550.1983. View

10.

Plumb M, Stein J, Stein G . Coordinate regulation of multiple histone mRNAs during the cell cycle in HeLa cells. Nucleic Acids Res. 1983; 11(8):2391-410. PMC: 325892. DOI: 10.1093/nar/11.8.2391. View

11.

Gunning P, Ponte P, Okayama H, Engel J, Blau H, Kedes L . Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Mol Cell Biol. 1983; 3(5):787-95. PMC: 368601. DOI: 10.1128/mcb.3.5.787-795.1983. View

12.

Feinberg A, Vogelstein B . A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983; 132(1):6-13. DOI: 10.1016/0003-2697(83)90418-9. View

13.

Frazier M, Mars W, Florine D, Montagna R, Saunders G . Efficient extraction of RNA from mammalian tissue. Mol Cell Biochem. 1983; 56(2):113-22. DOI: 10.1007/BF00227211. View

14.

Kelly K, Cochran B, Stiles C, Leder P . Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell. 1983; 35(3 Pt 2):603-10. DOI: 10.1016/0092-8674(83)90092-2. View

15.

Rothberg P, Erisman M, Diehl R, Rovigatti U, Astrin S . Structure and expression of the oncogene c-myc in fresh tumor material from patients with hematopoietic malignancies. Mol Cell Biol. 1984; 4(6):1096-103. PMC: 368878. DOI: 10.1128/mcb.4.6.1096-1103.1984. View

16.

Greenberg M, Ziff E . Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature. 1984; 311(5985):433-8. DOI: 10.1038/311433a0. View

17.

Dani C, Blanchard J, Piechaczyk M, El Sabouty S, Marty L, Jeanteur P . Extreme instability of myc mRNA in normal and transformed human cells. Proc Natl Acad Sci U S A. 1984; 81(22):7046-50. PMC: 392073. DOI: 10.1073/pnas.81.22.7046. View

18.

Elder P, Schmidt L, Ono T, Getz M . Specific stimulation of actin gene transcription by epidermal growth factor and cycloheximide. Proc Natl Acad Sci U S A. 1984; 81(23):7476-80. PMC: 392169. DOI: 10.1073/pnas.81.23.7476. View

19.

Khalili K, Weinmann R . Actin mRNAs in HeLa cells. Stabilization after adenovirus infection. J Mol Biol. 1984; 180(4):1007-21. DOI: 10.1016/0022-2836(84)90268-7. View

20.

Thompson C, Challoner P, Neiman P, Groudine M . Levels of c-myc oncogene mRNA are invariant throughout the cell cycle. Nature. 1985; 314(6009):363-6. DOI: 10.1038/314363a0. View